Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity.

Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.

View in: PubMed

collapse authors with profiles